Giuseppe Lombardi, Head of the Neuro-Oncology Unit at Veneto Oncology Institute IOV – IRCCS, shared a post on LinkedIn:
“MIRAGE trial: New treatment for patients with recurrent meningioma”
More posts featuring Giuseppe Lombardi
Giuseppe Lombardi/pugliaeccellente.info